ANEB
Anebulo Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.36
−8.05%Next report
Analyst consensus
- Next report date
- Sep 23, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- —
Latest reported
- Last report date
- Feb 12, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.13
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +32.6%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 23, 2026